Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acute Lymphoblastic Leukemia
53%
Acute Myeloid Leukemia
21%
Allogeneic Bone Marrow Transplantation
24%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
37%
Anemia Types
21%
Apoptosis
35%
Blood Transplantation
38%
Bone Marrow
51%
Bone Marrow Transplantation
43%
Chemotherapy
43%
Childhood Acute Lymphoblastic Leukemia
43%
Childhood Cancer Survivors
25%
Children with Cancer
16%
Congenital Dyserythropoietic Anemia
21%
Engraftment
29%
European Society
24%
Event-free Survival
44%
Ewing Sarcoma
47%
Ewing Sarcoma Family of Tumors
17%
Fanconi Anemia
16%
Fas Ligand
39%
Fertility Preservation
16%
Graft-versus-host Disease (GvHD)
21%
Hematopoietic Cells
21%
Hematopoietic Stem Cell Transplantation
46%
Hematopoietic Stem Cells
32%
High Dose
16%
High-risk Neuroblastoma
19%
Israel
43%
Israeli
38%
Leukemia
18%
Marrow Transplantation
38%
Neuroblastoma
67%
NOD Mice
16%
Overall Survival
36%
Pediatric
29%
Pediatric Diseases
23%
Pediatric Hematology
25%
Pediatric Hematopoietic Stem Cell Transplantation
19%
Pediatric Oncology
16%
Pediatric Patients
40%
Peripheral Blood Stem Cell Collection
16%
Quantitative PCR
20%
Risk Factors
20%
Stem Cell Transplantation
24%
T Cells
22%
Transplantation
39%
Tumor
32%
Working Diagnosis
24%
Working Party
20%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
49%
Acute Myeloid Leukemia
22%
Adolescence
36%
Allogeneic Hematopoietic Stem Cell Transplantation
16%
Anemia
11%
Bone Marrow Transplantation
33%
Cancer
12%
Central Venous Catheter
15%
Chemotherapy
54%
Childhood Cancer
26%
Cord Blood
16%
Cord Blood Stem Cell Transplantation
11%
Dinutuximab
15%
Diseases
100%
Drug Megadose
14%
Endocrine Disease
13%
Engraftment
21%
Event Free Survival
42%
Ewing Sarcoma
15%
Fas Ligand
26%
Fertility Preservation
16%
Ganglioneuroblastoma
63%
Graft Versus Host Reaction
20%
Hematopoietic Cell
22%
Hematopoietic Stem Cell Transplantation
57%
High Dose Chemotherapy
11%
Infection
16%
Leukemia
19%
Malignant Neoplasm
32%
Median Follow Up
18%
Melphalan
13%
Minimal Residual Disease
14%
Neoplasm
18%
Oncology
24%
Overall Survival
43%
Pediatric Disease
19%
Pediatric Hematology
20%
Pediatrics
80%
Pediatrics Patient
36%
Prognostic Factor
11%
Programmed Cell Death
17%
Retrospective Study
10%
Sickle-Cell Disease
14%
Solid Malignant Neoplasm
12%
Stem Cell
17%
Stem Cell Therapy
19%
Supportive Care
16%
T Cell
16%
Thalassemia Major
11%
Tumor
21%